a public good project by the
Synthesis
Company
of California

© 2026

Soichi Sakai | doi.page

0 works0 citations0 h-index

Soichi Sakai

Kanazawa University(JP)Kanazawa Medical University(JP)

Publications by Year

Research Areas

Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Renal Diseases and Glomerulopathies, Diabetes Management and Research

Most-Cited Works

→ SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria(2014)384 cited
→ Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study(2014)146 cited
→ Hypercalcemia after Renal Transplantation(1973)146 cited
Dermatologic evaluation of pruritus in patients on hemodialysis.(1973)
→ Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus(2015)83 cited
→ Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study(2014)63 cited
→

Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials

(2016)

63 cited

→ Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study(2014)60 cited

→ The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy(2000)58 cited

→ Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study(2014)56 cited